alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<TABLE> <S> <C>

<PAGE>

<ARTICLE>                     5
<LEGEND>
The schedule contains restated summary financial information extracted from the
Condensed Consolidated Statements of Operation for the Six Months Ended June 30,
1997 and the Condensed Consolidated Balance Sheet as of June 30, 1997 and is
qualified in its entirety by reference to such financial statements.
</LEGEND>
<RESTATED>
<MULTIPLIER>                                   1,000

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                              DEC-31-1997
<PERIOD-START>                                 JAN-01-1997
<PERIOD-END>                                   JUN-30-1997
<CASH>                                              38,977
<SECURITIES>                                             0
<RECEIVABLES>                                        5,038
<ALLOWANCES>                                            39
<INVENTORY>                                            156
<CURRENT-ASSETS>                                   115,686
<PP&E>                                              24,546
<DEPRECIATION>                                       2,262
<TOTAL-ASSETS>                                     173,457
<CURRENT-LIABILITIES>                                5,966
<BONDS>                                                513
<PREFERRED-MANDATORY>                                7,000
<PREFERRED>                                              1<F1>
<COMMON>                                                 7
<OTHER-SE>                                         154,571
<TOTAL-LIABILITY-AND-EQUITY>                       173,457
<SALES>                                              2,852
<TOTAL-REVENUES>                                    17,308
<CGS>                                                  626
<TOTAL-COSTS>                                       11,004
<OTHER-EXPENSES>                                     4,273
<LOSS-PROVISION>                                         0
<INTEREST-EXPENSE>                                       0
<INCOME-PRETAX>                                      2,301
<INCOME-TAX>                                           321
<INCOME-CONTINUING>                                  1,980
<DISCONTINUED>                                           0
<EXTRAORDINARY>                                          0
<CHANGES>                                                0
<NET-INCOME>                                         1,980
<EPS-PRIMARY>                                        (0.02)
<EPS-DILUTED>                                        (0.02)

<FN>
<F1> Represents par value of Reading Entertainment Series B Preferred Stock
</FN>

</TABLE>
'0 3-Q7'P 59 R

~ s&aYlC".~

+' ~. .

~

3

s

~

ADVISORY BoARD ON RADIAllON AND WORKER HEALm

4l>76 Columbia Parkway, MS: C-4l>

Cincinnati, ohio 45226

(513) 533-6825

January 20, 2007

The Honorable Ken Salazar, U.S. Senator

702 Hart Senate Office Building

Washington, D.C. 20510

CHAIRMAN:

Paul L. Ziemer, Ph.D.

laf8yett8, Indiana

The Honorable Mark Udall, U.S. Congressman

100 Cannon House Office Building

Washington, D.C. 20515

Bradley P. Clawson

Rexburg, Idaho The Honorable Ed Perlmutter, U.S. Congressman

415 Cannon House Office Building

Washington, D.C. 20515

Michael H. Gibson

Franklin, Ohio

Ma~A.Grtffon

Salem, New Hampshire

James E. Lockey, M.D.

Cincinnati, Ohio

Dear Mr. Salazar, Mr. Udall and Mr. Perlmutter:

The Advisory Board on Radiation and Worker Health would like to acknowledge

your letter of January 9, 2007. We appreciate your ongoing interest in the

Energy Employees Occupational Illness Compensation Program Act as it relates

to claimants from the Rocky Flats Plant.

James M. Melius, M.D., Ph.D

Albany, New York

Wanda I. Munn

Richland. Washington

John W. Poston. Sr., Ph.D.

College Station, Texas

Robert W. Presley

Clinton, Tennessee

Genevieve S. Roessler, Ph.D.

Elysian, Minnesota

STAFF:

We are writing to infonn you of the status of the deliberations of our Rocky Flats

Work Group and of action taken during the January II conference call of the

Board. The Rocky Flats Work Group has been working diligently with the

Board's contractor, SC&A, with NIOSH, and with the Rocky Flats SEC

petitioners to address and resolve issues concerning the Rocky Flats Site Profile

and related issues. As you know, we had hoped to complete this effort in time

for our February meeting (scheduled for Denver) so as to take formal action on

the petition for SEC status. Work Group Chairman Mark Griffon infonned the

Board during the January II conference call that in order to give all parties

sufficient time to review and evaluate the most recent documents, some of which

are not yet completed, it would be prudent to reschedule action on the Rocky

Flats petition until our May meeting. In addition, the Board is aware from your

letter that you are also recommending that action not be taken until the two

recently announced new members of the Board are officially seated. After taking

all these factors into consideration, the Board fonnally voted to reschedule action

on the Rocky Flats petition to the May 2007, meeting, and to hold that May

meeting in Denver. Representatives of the Rocky Flats SEC petition who were

present on the conference call indicated that they also concurred with this action.

EXECUTlVE SECRETARY:

lewis V. Wade, Ph.D

Washington, DC

COMMITTEE MANAGEMENT:

LaShawn D. Shields Atlanta, Georgia .

Sincerely,

~:~~~/~:;;::;~~'::_4.- 't-I

Paul L. Ziemer, Chainnan
Lightbridge Corp.: Exhibit 10.17 - Filed by newsfilecorp.com






Exhibit 10.17 

CHANGE ORDER NO. 07 TO 

AGREEMENT NO. EDC10017 (ECD-CON-10-001) 

BETWEEN 

EMIRATES NUCLEAR ENERGY CORPORATION

 (ENEC) 

AND 

LIGHTBRIDGE CORPORATION 

FOR 

NUCLEAR ENERGY CONSULTANCY SERVICES 




Emirates Nuclear Energy Corporation 

AGREEMENT CHANGE ORDER 


	
      Agreement No: EDC10017 (ECD-CON-10-001) 
	
      Change Order No.: 07 
	
      Date: 01 January 2013 

	
      Agreement Title: Nuclear Energy Consultancy
      Services 

	
      Contractor: Lightbridge Corporation 

	
      Change Order Duration: 01 January 2013 to 31
      December 2013 

	
      Preamble: 

	
      This Change Order No. 07 is Customer’s formal approval of
      the Change to the above Agreement No. EDC10017 (ECD-CON-10- 001).
  

	
      Change Order Details: 

	
      This Change Order No. 07 is made to renew the Agreement
      for one (1) year with effect from 01 January 2013 and to increase the
      Contract Value with an amount of USD 191,582.57. The Contract Value was
      USD 2,504,563.09 however only USD 2,423,888.65 was utilised until the end
      of 2012. Therefore, including the value of this Change Order, the Revised
      Contract Value will be USD 2,696,145.66 (Two Million, Six Hundred and
      Ninety Six Thousand, One Hundred and Forty Five United States Dollars and
      Sixty Six Cents only) 

	
      Effect on Agreement Schedule: 

	
      The Agreement is extended by 1 (one) year, from 01
      January 2013 to 31 December 2013. 

	
      Terms and Conditions: 

	
      Except as otherwise stated in Change Orders
      01,02,03,04,05,06 and this Change Order No. 07 all other terms and
      conditions of the original Agreement shall remain unchanged. 

	
      Effect on Agreement Price: 

	     •    
      Original Agreement Value (USD) 	1,877,l600.00 
	     •    
      Original Order No. 01 Value (USD) 	0.00 
	     •    
      Original Order No. 02 Value (USD) 	469,400.00 
	     •    
      Original Order No. 03 Value (USD) 	0.00 
	     •    
      Original Order No. 04 Value (USD) – Not utilised value 	(280,771.18) 
	     •    
      Original Order No. 04 Value (USD) – Renewal Budget 	136,129.00 
	     •    
      Original Order No. 05 Value (USD) 	31,309.55 
	     •    
      Original Order No. 06 Value (USD) 	270,895.72 
	     •    
      Original Order No. 07 Value (USD) 	191,582.57 
	Revised Contract Value (USD) 	2,696,145.66








SIGNATORIES 

IN WITNESS of which each of the parties has signed this
Agreement Change Order No. 07 on the Effective Date: 

	 	SIGNED by 	) 	By: 	 
	 	For and on behalf of Emirates Nuclear Energy 	) 	Name: 
	 	Corporation (ENEC) 	) 	Title: 
	 	  	  	Date: 
	 	  	  	  
	 	  	  	  
	 	  	  	  
	 	SIGNED by 	  	By: 	 
	 	for and on behalf of LIGHTBRIDGE 	  	Name: 
	 	CORPORATION 	  	Title: 
	 	  	  	Date:
Exhibit 32.1

CERTIFICATION PURSUANT TO

SECTION 1350, CHAPTER 63 OF TITLE 18, UNITED STATES CODE,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

Pursuant to Section 1350, Chapter 63 of Title 18, United States Code, as adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned, as Chief Executive Officer of AGY Holding Corp. (the Company), does hereby certify that to the undersigneds knowledge:

1) the Companys quarterly report on Form 10-Q for the quarter ended June 30, 2008 fully complies with the requirements of Section 13(a) or 15(d) of the
Securities Exchange Act of 1934; and

2) the information contained in the Companys quarterly report on Form 10-Q for the quarter ended June 30,
2008 fairly presents, in all material respects, the financial condition and results of operations of the Company.



|                                     
|-------------------------------------
|/s/ Douglas J. Mattscheck            
|Douglas J. Mattscheck                
|Chief Executive Officer and President
|(Principal Executive Officer)        
|                                     
|Dated: August 12, 2008               

A signed original of this written statement required by Section 906 has been provided to AGY Holding Corp.
and will be retained by AGY Holding Corp. and furnished to the Securities and Exchange Commission or its staff upon request.
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         Biomedical Library and Informatics Review Committee.                    

*Date:*                         March 6-7, 2008.                    

*Time:*                         March 6, 2008, 8 a.m. to 6 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         National Library of Medicine, Building 38, Board Room, 2nd Floor, 8600 Rockville Pike, Bethesda, MD 20892.                    

*Time:*                         March 7, 2008, 8 a.m. to 2 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         National Library of Medicine, Building 38, Board Room, 2nd Floor, 8600 Rockville Pike, Bethesda, MD 20892.                    

*Contact Person:*                         Arthur A Petrosian, PhD, Scientific Review Administrator, Division of Extramural Programs, National Library of Medicine, 6705 Rockledge Drive, Suite 301, Bethesda, MD 20892-7968, 301-496-4253,                         *petrosia@mail.nih.gov.*

(Catalogue of Federal Domestic Assistance Program Nos. 93.879, Medical Library Assistance, National Institutes of Health, HHS)

Dated: January 15, 2008.

Jennifer Spaeth,

Director, Office of Federal Advisory Committee Policy.

[FR Doc. 08-223  Filed 1-22-08; 8:45 am]

BILLING CODE 4140-01-M
Status of Upcoming 

Special Exposure Cohort (SEC) Petitions

LaVon B. Rutherford, CHP

National Institute for Occupational Safety and Health

Division of Compensation Analysis and Support

January 28, 2014

Kansas City, MO 
Purpose

 Provide an update to the Advisory Board on the 

current number of qualified petitions under 

evaluation and sites being evaluated through the 

83.14 process

 Provide SEC information to the Advisory Board in 

support of its preparations for future Work Group 

sessions and Advisory Board meetings
SEC Summary Table

(as of January 13, 2014)

 Petitions received 215

 Petitions in qualification process 1 

 Petitions qualified for evaluation 130

• NIOSH evaluation in progress 0

• NIOSH evaluation completed 130

– SEC Evaluation Reports 

 with the Advisory Board 

 for recommendation 8 

 Petitions not qualifying for evaluation 84

Note: Petitions not qualifying include five petitions received prior to the 

rule becoming final and Petition SEC-00034 (site was de-listed). 
SEC Petition Currently under Advisory 

Board Review

 Petition Evaluations the Advisory Board has taken 

action on, but are under continued evaluation:

• Hanford

• Los Alamos National Laboratory 

• Savannah River Site

• Nuclear Metals Inc.

• Joslyn Manufacturing and Supply Co.

• Oak Ridge National Laboratory 

• Rocky Flats Plant
SEC Petition Currently under Advisory 

Board Review—cont. 

 Petition Evaluations with the Advisory Board for 

initial action:

• Kansas City Plant
Potential SEC Petitions (83.14)

 Sandia National Laboratory – Albuquerque (1945-

1948)

 General Atomics (modify existing class definition)

 Dayton Project Monsanto (modify based on change 

in facility designation)

• Modify based on change in facility designation to a DOE 

facility

• Modify to add the 9 month period when operations were 

being shifted from “The Dayton Project” to Mound
SEC Petitions in 

Qualification/Evaluation

Qualification Process

 Linde Air Products – 1945-1947

Evaluation Process

 None
Exhibit 10.1

                          INTEREST-FREE LOAN AGREEMENT
                  This Agreement made on 2nd day of March 2015

This  Interest-free  Loan Agreement (The  "Agreement")  is made between from one
side Fellazo Corp.  (The  "Corporation"),  with its principal  office located at
str. Malina-Mica, nr 68/11- 419, Chisinau, Republic of Moldova, and from another
side Galina Hripcenco, (The "Director"),  where the Corporation and the Director
(The "Parties") has agreed to following:

In  circumstances  where  the  Corporation  requires  funds in  connection  with
business operations the Director has agreed to loan the amount of US$20,000 (the
"Loan amount") to the Corporation,  on certain terms and conditions contained in
this Agreement as following:

1. The  Director  hereby  agrees to loan up the Loan  amount to  Corporation  on
demand of the Corporation.

2. Loan funds advanced shall be non-interest  bearing,  secured and payable upon
demand.

3. Any additional funds that the Director loans to the Corporation subsequent to
this  Agreement  shall be subject to the same  terms as this  Agreement,  unless
otherwise agreed in writing.

4. In  accordance  to the  registration  statement  of the  Corporation,  if the
proceeds from the offering shares will not be sufficient, the Director will loan
to the Corporation needed funds to complete the registration process,  implement
business plan, and maintain reporting status and quotation on the OTC Electronic
Bulletin  Board or other  quotation  service,  which should not be more then the
Loan amount.

5. The Loan amount will be available for the  Corporation  until the Corporation
will start to earn significant  revenues,  sufficient for ongoing operations and
to pay all expenses.

6. The repayment of the Director's  Loan amount from the  Corporation  should be
started  when  the  Corporation  stars  to earn  significant  revenues  from its
operations.  The  repayment  will be made in  accordance to The Loaned amount of
funds by Director to the  Corporation  for the time period from  inception  till
last the Loan to the Corporation.

In witness  whereof the Parties  hereto have hereunto  affixed their  respective
hands, both as of the day and year first above written.

Authorized Signature


/s/ Galina Hripcenco
------------------------------------
Galina Hripcenco,
President & Director of Fellazo Corp.
AGENDA

Advisory Board on Radiation and Worker Health 

Teleconference Meeting of the 

TBD 6000 Work Group

September 25, 2017 

Conference Call Number: 1-866-659-0537

Participant Pass Code: 9933701

10:30 a.m. Eastern Time

Welcome and roll-call 

DISCUSSION

1. Review of DCAS Program Evaluation Report (PER) 63 (Alcoa – 

Pennsylvania) 

2. Action items/path forward

3. Review of PER 65(Anaconda)

4. Action items/path forward 

Adjourn
Presented at the ABRWH meeting 

Kansas City MO 

January 28, 2014 
Work Group Members 

 Paul Ziemer, Chair 

 Josie Beach 

 John Poston 

 Wanda Munn 
Activities Since the Last Board Meeting 

 Work Group met by telephone conferences on December 19, 

2013 and January 16, 2014. 

 Issues considered at December 19 meeting: 

1. Skin dose calculations and SC&A review of MCNPX calculations 

for betatron exposures 

2. DCAS review of the resuspension factor for the residual period 

3. DCAS review of report AEC NYO 4699 (identified by the copetitioner) for potential in selection of surrogate data 

 Issues considered at January 16 meeting: 

1. MCNPX calculations for neutron and other external exposures 

2. Resolution of Appendix BB Matrix Issues 

3. Impact of missing radium source on external exposure models 
Status of Appendix BB Issues Matrix 

 All open Issues were closed or designated in 

abeyance. 

 This includes several issues from the SEC Issues 

Matrix that were transferred to Appendix BB when 

the Work Group recommended that the SEC class be 

denied. 

 With the resolution of the issues, revision of 

Appendix BB by NIOSH can get underway. 
Summary of Appendix BB Issues Matrix 

1. Data sources: In abeyance 

2. Period of covered employment: Closed 

3. Betatron beam intensity: Closed 

4. Underestimate of stray betatron radiation (Includes 

Issues 2, 6, & 8 from SEC Issues Matrix): In abeyance 

5. Other radiography sources (Includes Issue 3 from SEC 

Issues Matrix): Closed 

6. Skin dose (Includes Issue 9 from SEC Issues Matrix): In 

abeyance 
Summary of Appendix BB Issues Matrix 

(continued) 

7. Residual radiation from betatron apparatus: Closed 

8. Work hours: Closed 

9. Work practices: In abeyance 

10. Dose rates from uranium: In abeyance 

11. Doses to other workers: In abeyance 

12. Surface contamination and resuspension: In abeyance 

13. Incorrect units: In abeyance 
Lost Radium Source Issue 

 Discussions of the possibility of a missing source go back several 

years including worker testimony in 2006 & 2007. 

 Site Expert subsequently located newspapers articles confirming 

that one of the radium radiography sources (500 mCi) was 

missing for about one week in October 1953. 

 News articles also indicated that there was an ongoing search for 

the source, and that it was eventually located off-site. 

 Co-petitioner also indicates that one GSI clerk recalled that the 

person who removed (took) the source got sick, was 

hospitalized, and died as a result of radiation injury. This appears 

to conflict with testimony from GSI officials. 

 One recently located news account was not available at the 

January 16 meeting, so a final decision on how NIOSH would 

evaluate this situation was deferred.
AGENDA

Advisory Board on Radiation and Worker Health

Metals & Controls Work Group Meeting

December 6, 2023

Videoconference:

Join ZoomGov Meeting

https://cdc.zoomgov.com/j/16067633819?pwd=RUdiYXlZZHFKanpJOHZrcGJIbTlaZz09

Teleconference:

Phone: +1 (646) 828-7666 (U.S. East)

Phone: +1 (669) 254-5252 (U.S. West)

Meeting ID: 160 6763 3819

Passcode: 98685439

11:00 a.m. (Eastern Time) Start

Welcome and Roll Call

1. NIOSH Response to “SC&A Review [April 2023] of NIOSH Response [January 2023] to 

SC&A’s Supplemental Review of M&C Work Group Issues [August 2022]

2. “Review of Overall NIOSH Response and SEC Issues under Consideration” (SC& 

presentation)

3. Petitioner Comments (optional to Petitioner)

4. Workgroup Discussion

5. Workgroup Discussion of Path Forward

Adjourn
AGENDA 

Advisory Board on Radiation and Worker Health 

Meeting of the 

TBD 6000 Working Group (WG) 

April 1, 2021 

10:30 a.m. (Eastern Time) 

Videoconference: 

Join ZoomGov Meeting 

https://cdc.zoomgov.com/j/16067633819?pwd=RUdiYXlZZHFKanpJOHZrcGJIbTlaZz09 

Meeting ID: 160 6763 3819 

Passcode: ABRWH#01 

Teleconference: 

Phone: (646) 828-7666 

Meeting ID: 160 6763 3819 

Participants ID: # 

Meeting Password: 98685439 

Welcome and roll-call/introductions 

1. NIOSH Response Paper- Additional Information in Response to SEC-00247 ER Review 

Finding #1 

a. NIOSH Presentation 

b. SC&A Presentation 

c. WG Discussion 

2. Work Group Discussion, Actions 

3. Path Forward 

Adjourn
UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM N-PX
                ANNUAL REPORT OF PROXY VOTING RECORD OF REGISTERED
                         MANAGEMENT INVESTMENT COMPANIES

                    Investment Company Act file number 811-02704
                                                           -----

Pioneer Tax Free Income Fund
----------------------------------------------------
(Exact name of registrant as specified in charter)

60 State Street Boston, MA  02109
----------------------------------------------------
(Address of principal executive offices)

Dorothy Bourassa
60 State Street
Boston, MA  02109
----------------------------------------------------
(Name and address of agent for service)

Registrant's telephone number, including area code:  (617) 742-7825

Date of fiscal year end:  December 31

Date of reporting period:  July 1, 2007 to June 30, 2008

SIGNATURES

Pursuant to the requirements of the Investment Company Act of 1940, the
registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.

(Registrant)  Pioneer Tax Free Income Fund

By (Signature and Title)  /s/ John F. Cogan, Jr.
                         -------------------------
                         John F. Cogan, Jr., Chairman and President

Date  August 19, 2008
      ----------------


========================= PIONEER TAX FREE INCOME FUND =========================



The Fund held no securities during the period covered by this report in which
there was a securityholder vote.  Accordingly, there are no proxy votes to
report.



========== END NPX REPORT